Skip to content
My WebMD Sign In, Sign Up

HPV/Genital Warts Health Center

Font Size
A
A
A

Late Doses of HPV Vaccine May Still Be Effective

Study: Girls Still Get Protection When Shots Are Given Months Later Than Recommended
By
WebMD Health News
Reviewed by Laura J. Martin, MD

12 year old girl

April 12, 2011 -- Delaying doses of a vaccine that protects against cervical cancer doesn’t appear to make it any less safe or effective, a new study shows.

The vaccine against human papilloma virus (HPV) is given in three shots over a period of six months.

Research has shown that the vaccine is highly effective at blocking the strains of HPV responsible for causing about 70% of all cervical cancer cases.

But several recent studies have shown that most women and girls who start the shots don’t get them on time, if they finish the series at all.

“This study should be very reassuring,” says Kathleen M. Neuzil, MD, MPH, clinical associate professor of allergy and infectious diseases in the department of global health at the University of Washington in Seattle. Neuzil is also the senior advisor for immunizations at the international nonprofit organization PATH, which is also based in Seattle.

“Certainly clinicians and parents can be reassured that if there are delays, as we know occur, this vaccine still works very well,” says Neuzil.

Other experts who have studied the problem of HPV vaccine compliance agree.

“About half of those who start the HPV series actually complete it, and really, only a quarter are completing it on time,” says Emmanuel B. Walter, MD, MPH, professor of pediatrics at Duke University in Durham, N.C.

“This gives us hope that it’s OK if girls get their doses late,” says Walter, who published a study on HPV vaccine compliance in the March 2011 issue of Vaccine. “I say that with the caveat that we don’t know exactly what protection is or how effective the vaccine is only after two doses or one dose of the vaccine.”

Comparing HPV Vaccine Schedules

For the study, Neuzil and her team enrolled 903 girls between the ages of 11 and 13 at 21 different schools in rural Vietnam.

The schools were randomly assigned to give three doses of the HPV vaccine to the girls participating in the study on one of four different dosing schedules:

  • The recommended schedule at 0, 2, and 6 months.
  • A timetable where the shots were spaced over the school year: 0, 3, and 9 months.
  • A shot every six months for one year: 0, 6, and 12 months.
  • A shot every 12 months for two years: 0, 12, and 24 months.

More than 800 girls completed all three doses, and researchers gave them blood tests after each shot to measure levels of antibodies against two cancer-causing HPV strains.

Compared to girls who got their doses on the recommended six-month timetable, researchers found that girls on the 9- and 12-month dosing schedules had only slight dips in their antibody levels, which weren’t expected to be clinically meaningful.

Today on WebMD

HPV Vaccine Future
Article
STD Overview
Slideshow
 
STD Facts Quiz
Quiz
Syringes and graph illustration
Tool
 
Sex Drive Killers
Slideshow
Genital Herpes Risks Quiz
Quiz
 
Young couple holding hands
Quiz
Herpes Vaccine Study
Video
 
Condom Quiz
Quiz
HPV Symptoms Tests
Medical Reference
 
Get The STD Picture
Feature
mother and daughter talking
Tool
 

WebMD Special Sections